MarketCap
Facebook
X
Telegram
Guardant Health EBITDA per Share | GH
Annual EBITDA per Share Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.17 | -3.27 | -4.66 | -4.98 | -3.84 | -2.45 | -0.759 | -2.82 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.759 | -4.98 | -3.24 |
Quarterly EBITDA per Share Guardant Health
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.83 | -0.85 | -0.56 | -0.78 | -0.81 | - | -0.87 | -0.74 | -0.73 | - | -0.88 | -1.01 | -1.21 | - | -1.32 | -1.2 | -1.14 | - | -0.9 | -0.91 | -1.02 | - | -0.63 | -0.49 | -0.33 | - | -0.1 | -0.12 | -0.25 | 0.07 | -1.53 | -1.59 | -1.45 | - | -2.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.07 | -2.06 | -0.866 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B |  USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Syneos Health
SYNH
|
6.32 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K |  Israel |
 |
Renalytix AI plc
RNLX
|
-0.27 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Psychemedics Corporation
PMD
|
-0.14 | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
-0.95 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
T2 Biosystems
TTOO
|
-18.7 | - | -39.35 % | $ 313 K | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Bioventus
BVS
|
1.52 | $ 13.0 | 1.39 % | $ 866 M | USA |
 |
DarioHealth Corp.
DRIO
|
-9.13 | $ 6.75 | 2.31 % | $ 26.9 M | Israel |
 |
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.69 | 1.45 % | $ 87.3 K | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
-2.94 | $ 27.7 | 1.09 % | $ 209 M | USA |
 |
BioNano Genomics
BNGO
|
-4.37 | $ 1.56 | 17.29 % | $ 8.49 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 11.68 | 0.69 % | $ 123 M |  China |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 52.64 | 0.52 % | $ 2.81 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 82.7 | 0.1 % | $ 3.87 B | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.14 | 2.7 % | $ 1.52 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 272.88 | 0.59 % | $ 13.5 B | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 35.5 | 6.16 % | $ 1.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 247.08 | 3.9 % | $ 27.4 B | USA |
 |
Meridian Bioscience
VIVO
|
1.63 | - | - | $ 1.49 B | USA |
 |
Biomerica
BMRA
|
-1.8 | $ 2.3 | 0.42 % | $ 6.7 M | USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 21.28 | 3.05 % | $ 655 M | USA |
 |
ICON Public Limited Company
ICLR
|
10.5 | $ 172.45 | 2.08 % | $ 13.5 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
18.7 | $ 510.73 | 0.23 % | $ 41.1 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 209.36 | 3.01 % | $ 149 B | USA |
 |
Illumina
ILMN
|
6.95 | $ 222.29 | 6.76 % | $ 34.5 B | USA |
 |
IQVIA Holdings
IQV
|
19.4 | $ 269.67 | 1.51 % | $ 46.4 B | USA |
 |
Brainsway Ltd.
BWAY
|
0.04 | $ 13.46 | 0.14 % | $ 457 M | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 323.97 | 2.75 % | $ 27 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 100.73 | 0.41 % | $ 6.8 B | USA |
 |
DexCom
DXCM
|
2.98 | $ 86.45 | 2.09 % | $ 33.7 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 620.48 | 4.21 % | $ 17.9 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 330.4 | 3.47 % | $ 27.4 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.88 | 2.37 % | $ 359 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 5.66 | 1.13 % | $ 4.45 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 18.89 | 2.61 % | $ 2.42 B | USA |
 |
Neogen Corporation
NEOG
|
0.44 | $ 12.25 | 2.51 % | $ 2.66 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 21.96 | 5.63 % | $ 492 M | USA |
 |
Natera
NTRA
|
-1.96 | $ 350.78 | 2.63 % | $ 48 B | USA |
 |
OPKO Health
OPK
|
-0.03 | $ 1.57 | 0.64 % | $ 1.18 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.34 | 0.37 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 24.9 | 1.99 % | $ 23.6 B |  Niderland |
 |
Personalis
PSNL
|
-0.87 | $ 16.1 | 0.31 % | $ 1.44 B | USA |